Related references
Note: Only part of the references are listed.Epidemiology of Renal Cell Carcinoma
Umberto Capitanio et al.
EUROPEAN UROLOGY (2019)
mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
Tian Tian et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Genetic and metabolic hallmarks of clear cell renal cell carcinoma
Danielle J. Sanchez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma
Michael B. Atkins et al.
CANCER TREATMENT REVIEWS (2018)
Inhibition of Glycolysis and Glutaminolysis: An Emerging Drug Discovery Approach to Combat Cancer
Nicholas S. Akins et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Overexpression of PLIN2 is a prognostic marker and attenuates tumor progression in clear cell renal cell carcinoma
Qi Cao et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Pyruvate kinase M2 fuels multiple aspects of cancer cells: from cellular metabolism, transcriptional regulation to extracellular signaling
Ming-Chuan Hsu et al.
MOLECULAR CANCER (2018)
Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies
Peter Makhov et al.
MOLECULAR CANCER THERAPEUTICS (2018)
TOFA induces cell cycle arrest and apoptosis in ACHN and 786-O cells through inhibiting PI3K/Akt/mTOR pathway
Dejiao He et al.
JOURNAL OF CANCER (2018)
Expression and significance of Cystatin-C in clear cell renal cell carcinoma
Kunbin Guo et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Novel SIRT1 inhibitor 15-deoxy-Δ12,14-prostaglandin J2 and its derivatives exhibit anticancer activity through apoptotic or autophagic cell death pathways in SKOV3 cells
In Hwan Tae et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2018)
Nomograms for predicting long-term overall survival and disease-specific survival of patients with clear cell renal cell carcinoma
Guanghao Zhang et al.
ONCOTARGETS AND THERAPY (2018)
Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways
Ji Yeon Son et al.
CANCER MEDICINE (2018)
Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling
Shurui Chen et al.
PLOS ONE (2017)
PKM2 promotes cell migration and inhibits autophagy by mediating PI3K/AKT activation and contributes to the malignant development of gastric cancer
Chao Wang et al.
SCIENTIFIC REPORTS (2017)
The current status of immunobased therapies for metastatic renal-cell carcinoma
Niranjan J. Sathianathen et al.
IMMUNOTARGETS AND THERAPY (2017)
The Evolution of Clinical Trials in Renal Cell Carcinoma: A Status Report for 2013-2016 from the ClinicalTrials.gov Website
Pooja Ghatalia et al.
KIDNEY CANCER (2017)
Overexpression of KiSS-1 reduces colorectal cancer cell invasion by downregulating MMP-9 via blocking PI3K/Akt/NF-κB signal pathway
Shaoqin Chen et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
MiR-144 Inhibits Cell Proliferation of Renal Cell Carcinoma by Targeting MTOR
Cheng Xiang et al.
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES (2016)
PKM2-dependent glycolysis promotes NLRP3 and AIM2 inflammasome activation
Min Xie et al.
NATURE COMMUNICATIONS (2016)
Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1
Chang-Liang He et al.
SCIENTIFIC REPORTS (2016)
Pyruvate kinase M2 at a glance
Weiwei Yang et al.
JOURNAL OF CELL SCIENCE (2015)
The PI3K/AKT Pathway and Renal Cell Carcinoma
Huifang Guo et al.
JOURNAL OF GENETICS AND GENOMICS (2015)
Knockdown of PKM2 induces apoptosis and autophagy in human A549 alveolar adenocarcinoma cells
Beibei Chu et al.
MOLECULAR MEDICINE REPORTS (2015)
Primary clear cell renal carcinoma cells display minimal mitochondrial respiratory capacity resulting in pronounced sensitivity to glycolytic inhibition by 3-Bromopyruvate
H. Nilsson et al.
CELL DEATH & DISEASE (2015)
PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation
Valeria Iansante et al.
NATURE COMMUNICATIONS (2015)
Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism
Sandra Leisz et al.
ONCOTARGET (2015)
PKM2 Regulates Hepatocellular Carcinoma Cell Epithelial-mesenchymal Transition and Migration upon EGFR Activation
Fang-Tian Fan et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)
Role of pyruvate kinase M2 in transcriptional regulation leading to epithelial-mesenchymal transition
Atsushi Hamabe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
Altered energy metabolism in cancer A unique opportunity for therapeutic intervention
Yi Zhang et al.
CANCER BIOLOGY & THERAPY (2013)
Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States
Dan Y. Gui et al.
SCIENCE SIGNALING (2013)
Recent developments in the treatment of renal cell carcinoma
Janice P. Dutcher
THERAPEUTIC ADVANCES IN UROLOGY (2013)
PKM2 Phosphorylates Histone H3 and Promotes Gene Transcription and Tumorigenesis
Weiwei Yang et al.
CELL (2012)
Remarkable inhibition of mTOR signaling by the combination of rapamycin and 1,4-phenylenebis(methylene)selenocyanate in human prostate cancer cells
Nicole D. Facompre et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression
Michael S. Goldberg et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Ethanol extracts of fruiting bodies of Antrodia cinnamomea exhibit anti-migration action in human adenocarcinoma CL1-0 cells through the MAPK and PI3K/AKT signaling pathways
Ying-Yi Chen et al.
PHYTOMEDICINE (2012)
Global Gene Expression Profiling and Validation in Esophageal Squamous Cell Carcinoma and Its Association with Clinical Phenotypes
Hua Su et al.
CLINICAL CANCER RESEARCH (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells
Alfredo Toschi et al.
CANCER LETTERS (2010)
A Unique Metastasis Gene Signature Enables Prediction of Tumor Relapse in Early-Stage Hepatocellular Carcinoma Patients
Stephanie Roessler et al.
CANCER RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
Ju-Seog Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Tumor suppressors and cell metabolism: a recipe for cancer growth
Russell G. Jones et al.
GENES & DEVELOPMENT (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Heather R. Christofk et al.
NATURE (2008)
Mesenchymal stem cells within tumour stroma promote breast cancer metastasis
Antoine E. Karnoub et al.
NATURE (2007)
Activation of the mTOR signaling pathway in renal clear cell carcinoma
Victoria A. Robb et al.
JOURNAL OF UROLOGY (2007)
Anti-invasive and anti-metastasis strategies:: New roads, new tools and new hopes
Laurent Dolle et al.
CURRENT CANCER DRUG TARGETS (2006)
Ras, PI(3)K and mTOR signalling controls tumour cell growth
Reuben J. Shaw et al.
NATURE (2006)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes
HK Nair et al.
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY (2004)
Gene-expression profiles predict survival of patients with lung adenocarcinoma
DG Beer et al.
NATURE MEDICINE (2002)
Share Paper
